Eguchi Hidetoshi, Nagano Hiroaki, Sakon Masato, Miyamoto Atsushi, Kondo Motoi, Arai Isao, Morimoto Osakuni, Dono Keizo, Umeshita Koji, Nakamori Shoji, Wakasa Kenichi, Monden Morito
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Japan.
Surg Today. 2002;32(8):742-6. doi: 10.1007/s005950200140.
Because of the low incidence rate of combined hepatocellular-cholangiocarcinoma (combined HCC-CC), the clinicopathological features of a recurrent tumor of this disease remain to be elucidated. We describe a 47-year-old Japanese woman with a 5-cm diameter mass lesion in the liver. A hepatectomy and dissection of the local lymph nodes were performed and a histological examination of the resected specimen showed combined HCC-CC. After a follow-up of 15 months, intrahepatic recurrence was observed, and a hepatectomy was performed again followed by hepatic arterial infusion chemotherapy. A histological examination revealed that the recurrent tumors consisted of only cholangioacarcinoma. A disease-free survival was obtained for about 7 years after the recurrence. To improve the poor prognosis of combined HCC-CC, clinicopathological features of this disease and the therapy selection for recurrent tumors should be discussed.
由于肝细胞癌-胆管癌(HCC-CC)合并症的发病率较低,该疾病复发性肿瘤的临床病理特征仍有待阐明。我们描述了一名47岁的日本女性,其肝脏有一个直径5厘米的肿块病变。进行了肝切除术和局部淋巴结清扫术,切除标本的组织学检查显示为HCC-CC合并症。随访15个月后,观察到肝内复发,再次进行了肝切除术,随后进行了肝动脉灌注化疗。组织学检查显示,复发性肿瘤仅由胆管癌组成。复发后无病生存期约为7年。为改善HCC-CC合并症的不良预后,应讨论该疾病的临床病理特征以及复发性肿瘤的治疗选择。